On Tuesday shares of Endocyte, Inc. (NASDAQ:ECYT) closed at $5.98. Company’s sales growth for last 5 years was 88.00%. Endocyte, Inc. (NASDAQ:ECYT) announced that data from the PROCEED Study presented at the 2015 Annual Meeting on Women’s Cancer in Chicago on Saturday, March 28 in Chicago.

ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity increased 2.15% to close at $9.50. Company weekly performance is 11.50% while its quarterly performance stands at 45.48%. ImmunoGen, Inc. (NASDAQ:IMGN) is -35.98% away from its 52 week high. On April 3, 2015, ImmunoGen, Inc. (NASDAQ:IMGN) and a subsidiary completed the previously announced royalty transaction with Immunity Royalty Holdings, L.P.

On last trading day Reinsurance Group of America Inc. (NYSE:RGA) moved down -0.84% to close at $92.75. Its volatility for the week is 1.03% while volatility for the month is 1.25%. RGA’s sales growth for past 5 years was 8.70% and its EPS growth for past 5 years was 12.00%. Reinsurance Group of America Inc. (NYSE:RGA) monthly performance is 2.99%. Reinsurance Group of America, Incorporated (NYSE:RGA) plans to release first-quarter earnings on Thursday, April 23, at approximately 4:15 p.m. Eastern Time.

Alexco Resource Corporation (NYSEMKT:AXU) has 12.34% insider ownership while its institutional ownership stands at 34.00%. In last trading activity company’s stock closed at $0.36. Alexco Resource Corp. (NYSE:AXU) was upgraded by equities researchers at Cormark to a “market perform” rating in a research report issued on Friday.

Celgene Corporation (NASDAQ:CELG) in last trading activity decreased -0.22% to close at $112.72. Company weekly performance is -6.08% while its quarterly performance stands at 0.71%. Celgene Corporation (NASDAQ:CELG) is -12.66% away from its 52 week high. OncoMed is developing demcizumab in collaboration with Celgene Corporation (NASDAQ:CELG).